文献速递浆细胞疾病淋巴瘤

多发性骨髓瘤骨髓中CD69-与CD69+终末效应T细胞呈反向关系

Inverse relationship between oligoclonal expanded CD69- TTE and CD69+ TTE cells in bone marrow of multiple myeloma patients.
PubMed 文献 · Blood Adv · 2020-01-01

研究用流式、质谱流式和FlowSOM聚类分析年龄匹配对照及MGUS、SMM、NDMM患者骨髓和外周血中CD8+CD57+终末效应T细胞。骨髓含CD69-和CD69+亚群而外周血仅CD69-;对照骨髓两者比例相当,MGUS/SMM以CD69-为主,NDMM呈一方优势,且对照中正相关在MGUS消失、NDMM转为反向。CD69-含骨髓与外周血共享的寡克隆扩增,外周血中具骨髓瘤反应性、可杀伤自体CD38hi浆细胞;CD69+无寡克隆扩增、穿孔素颗粒酶低、抑制性检查点高,类似组织驻留记忆T细胞。

要点

  • 骨髓终末效应T细胞含CD69-和CD69+亚群,外周血仅见CD69-亚群。
  • 对照骨髓CD69-与CD69+比例相当,MGUS/SMM以CD69-为主,NDMM呈一方优势。
  • CD69-与CD69+的关系由对照的正相关,在MGUS消失、NDMM转为反向。

核心结论

  • 骨髓终末效应T细胞区室中CD69-与CD69+细胞的平衡可能调控NDMM免疫反应并贡献疾病临床异质性。

研究设计与样本

  • 采用流式细胞术、质谱流式细胞术和FlowSOM聚类,分析年龄匹配对照及MGUS、SMM、NDMM患者骨髓和外周血的CD8+CD57+终末效应T细胞。

主要发现

  • 终末效应T细胞在所有受试者中呈异质性,骨髓含CD69-和CD69+亚群,外周血仅见CD69-细胞。
  • 对照骨髓中CD69-与CD69+比例相当,MGUS和SMM以CD69-为主,NDMM以CD69-或CD69+一方为主。
  • 对照骨髓中CD69+与CD69-终末效应T细胞呈正相关,MGUS中消失,NDMM转为反向关系。
  • NDMM骨髓和外周血共享CD69-终末效应T细胞的多个TCR/Vβ家族寡克隆扩增。
  • 外周血寡克隆扩增的CD69-终末效应T细胞含骨髓瘤反应性细胞,体外可杀伤自体CD38hi浆细胞,涉及脱颗粒及穿孔素、颗粒酶高表达。

临床怎么用

  • 检测骨髓终末效应T细胞CD69-与CD69+亚群比例及平衡,可能辅助评估NDMM免疫状态与疾病异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CD8+CD57+ terminal effector T (TTE) cells are a component of marrow-infiltrating lymphocytes and may contribute to the altered immune responses in multiple myeloma (MM) patients. We analyzed TTE cells in the bone marrow (BM) and peripheral blood (PB) of age-matched controls and patients with monoclonal gammopathy of undetermined significance (MGUS), smoldering MM (SMM), and newly diagnosed (ND) MM using flow cytometry, mass cytometry, and FlowSOM clustering. TTE cells are heterogeneous in all subjects, with BM containing both CD69- and CD69+ subsets, while only CD69- cells are found in PB. Within the BM-TTE compartment, CD69- and CD69+ cells are found in comparable proportions in controls, while CD69- cells are dominant in MGUS and SMM and predominantly either CD69- or CD69+ cells in NDMM. A positive relationship between CD69+TTE and CD69-TTE cells is observed in the BM of controls, lost in MGUS, and converted to an inverse relationship in NDMM. CD69-TTE cells include multiple oligoclonal expansions of T-cell receptor/Vβ families shared between BM and PB of NDMM. Oligoclonal expanded CD69-TTE cells from the PB include myeloma-reactive cells capable of killing autologous CD38hi plasma cells in vitro, involving degranulation and high expression of perforin and granzyme. In contrast to CD69-TTE cells, oligoclonal expansions are not evident within CD69+TTE cells, which possess low perforin and granzyme expression and high inhibitory checkpoint expression and resemble T resident memory cells. Both CD69-TTE and CD69+TTE cells from the BM of NDMM produce large amounts of the inflammatory cytokines interferon-γ and tumor necrosis factor α. The balance between CD69- and CD69+ cells within the BM-TTE compartment may regulate immune responses in NDMM and contribute to the clinical heterogeneity of the disease.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Vuckovic S, Bryant CE, Lau KHA, et al. Inverse relationship between oligoclonal expanded CD69- TTE and CD69+ TTE cells in bone marrow of multiple myeloma patients. Blood Adv. 2020. PMID: 32986791. doi:10.1182/bloodadvances.2020002237

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。